{"id":950,"date":"2016-07-05T06:22:57","date_gmt":"2016-07-05T11:22:57","guid":{"rendered":"http:\/\/www.masstortlawyerblog.com\/?p=950"},"modified":"2018-04-12T12:39:33","modified_gmt":"2018-04-12T17:39:33","slug":"moll-law-group-archiva-primera-demanda-contra-aztrazeneca-debido-lesiones-causadas-por-nexium","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/moll-law-group-archiva-primera-demanda-contra-aztrazeneca-debido-lesiones-causadas-por-nexium\/","title":{"rendered":"Moll Law Group Archiva Primera Demanda Contra AztraZeneca Debido a Lesiones Causadas por Nexium"},"content":{"rendered":"<p>Moll Law Group ha presentado su primera demanda contra el fabricante de Nexium, AstraZeneca, en nombre de un residente de Tennessee que sufri\u00f3 heridas graves y potencialmente mortales despu\u00e9s de haber sido prescrito y de tomar el medicamento Nexium. Presentada en el Distrito Oeste de Tennessee, la demanda alega que los acusados sab\u00edan o deber\u00edan de haber sabido que Nexium formula un serio <a href=\"http:\/\/www.cbsnews.com\/news\/common-heartburn-drugs-linked-with-kidney-disease\/\">riesgo<\/a> de lesiones renales y que el fabricante de medicamentos fallo en proporcionar las instrucciones adecuadas en relaci\u00f3n con las consecuencias potencialmente mortales que podr\u00edan resultar del uso de la droga.<\/p>\n<p>El demandante comenz\u00f3 a tomar Nexium en el 2003 y continu\u00f3 utiliz\u00e1ndolo hasta el 2008, cuando fue diagnosticado con una condici\u00f3n grave e inducida por f\u00e1rmacos de nefritis intersticial aguda a trav\u00e9s de una biopsia. Como resultado de su condici\u00f3n, \u00e9l estaba obligado a someterse a di\u00e1lisis tres veces a la semana y est\u00e1 en espera de un trasplante de ri\u00f1\u00f3n.<\/p>\n<p>Nexium es un tipo de inhibidor de la bomba de protones (IBP) que se utiliza para disminuir la cantidad de \u00e1cido que produce el est\u00f3mago. Este tipo de medicamento se utiliza com\u00fanmente para tratar la enfermedad de reflujo gastroesof\u00e1gico (ERGE) y la \u00falcera p\u00e9ptica (PUD). Aprobado originalmente bajo el nombre de Losec en 1988, Nexium es un medicamento IBP de segunda generaci\u00f3n y se pretende que sea una mejor\u00eda de la versi\u00f3n de primera generaci\u00f3n, com\u00fanmente conocida como Prilosec. <a href=\"https:\/\/www.molllawgroup.com\/blog\/moll-law-group-archiva-primera-demanda-contra-aztrazeneca-debido-lesiones-causadas-por-nexium\/#more-950\" class=\"more-link\">Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Moll Law Group ha presentado su primera demanda contra el fabricante de Nexium, AstraZeneca, en nombre de un residente de Tennessee que sufri\u00f3 heridas graves y potencialmente mortales despu\u00e9s de haber sido prescrito y de tomar el medicamento Nexium. Presentada en el Distrito Oeste de Tennessee, la demanda alega que los acusados sab\u00edan o deber\u00edan [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"class_list":["post-950","post","type-post","status-publish","format-standard","hentry","category-en-espanol"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Moll Law Group Archiva Primera Demanda Contra AztraZeneca Debido a Lesiones Causadas por Nexium &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; July 5, 2016<\/title>\n<meta name=\"description\" content=\"Moll Law Group ha presentado su primera demanda contra el fabricante de Nexium, AstraZeneca, en nombre de un residente de Tennessee que sufri\u00f3 heridas &#8212; July 5, 2016\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/moll-law-group-archiva-primera-demanda-contra-aztrazeneca-debido-lesiones-causadas-por-nexium\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Moll Law Group Archiva Primera Demanda Contra AztraZeneca Debido a Lesiones Causadas por Nexium &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; July 5, 2016\" \/>\n<meta name=\"twitter:description\" content=\"Moll Law Group ha presentado su primera demanda contra el fabricante de Nexium, AstraZeneca, en nombre de un residente de Tennessee que sufri\u00f3 heridas &#8212; July 5, 2016\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Moll Law Group Archiva Primera Demanda Contra AztraZeneca Debido a Lesiones Causadas por Nexium &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; July 5, 2016","description":"Moll Law Group ha presentado su primera demanda contra el fabricante de Nexium, AstraZeneca, en nombre de un residente de Tennessee que sufri\u00f3 heridas &#8212; July 5, 2016","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/moll-law-group-archiva-primera-demanda-contra-aztrazeneca-debido-lesiones-causadas-por-nexium\/","twitter_card":"summary_large_image","twitter_title":"Moll Law Group Archiva Primera Demanda Contra AztraZeneca Debido a Lesiones Causadas por Nexium &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; July 5, 2016","twitter_description":"Moll Law Group ha presentado su primera demanda contra el fabricante de Nexium, AstraZeneca, en nombre de un residente de Tennessee que sufri\u00f3 heridas &#8212; July 5, 2016","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/moll-law-group-archiva-primera-demanda-contra-aztrazeneca-debido-lesiones-causadas-por-nexium\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/moll-law-group-archiva-primera-demanda-contra-aztrazeneca-debido-lesiones-causadas-por-nexium\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"Moll Law Group Archiva Primera Demanda Contra AztraZeneca Debido a Lesiones Causadas por Nexium","datePublished":"2016-07-05T11:22:57+00:00","dateModified":"2018-04-12T17:39:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/moll-law-group-archiva-primera-demanda-contra-aztrazeneca-debido-lesiones-causadas-por-nexium\/"},"wordCount":687,"articleSection":["Art\u00edculos Publicados En Espa\u00f1ol"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/moll-law-group-archiva-primera-demanda-contra-aztrazeneca-debido-lesiones-causadas-por-nexium\/","url":"https:\/\/www.molllawgroup.com\/blog\/moll-law-group-archiva-primera-demanda-contra-aztrazeneca-debido-lesiones-causadas-por-nexium\/","name":"Moll Law Group Archiva Primera Demanda Contra AztraZeneca Debido a Lesiones Causadas por Nexium &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; July 5, 2016","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"datePublished":"2016-07-05T11:22:57+00:00","dateModified":"2018-04-12T17:39:33+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"Moll Law Group ha presentado su primera demanda contra el fabricante de Nexium, AstraZeneca, en nombre de un residente de Tennessee que sufri\u00f3 heridas &#8212; July 5, 2016","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/moll-law-group-archiva-primera-demanda-contra-aztrazeneca-debido-lesiones-causadas-por-nexium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/moll-law-group-archiva-primera-demanda-contra-aztrazeneca-debido-lesiones-causadas-por-nexium\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/moll-law-group-archiva-primera-demanda-contra-aztrazeneca-debido-lesiones-causadas-por-nexium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Moll Law Group Archiva Primera Demanda Contra AztraZeneca Debido a Lesiones Causadas por Nexium"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/950","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=950"}],"version-history":[{"count":1,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/950\/revisions"}],"predecessor-version":[{"id":1620,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/950\/revisions\/1620"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=950"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=950"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=950"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}